Developers: | Biotronik |
Date of the premiere of the system: | August 2023 |
Branches: | Pharmaceuticals, Medicine, Healthcare |
2023: First implantation
On August 29, 2023, the private medical company Biotronik announced the world's first operation to implant a next-generation pacemaker Amvia Edge equipped with an MRI sensor.
The device supports the MRI Guard 24/7 function, which monitors the presence of a field generated by magnetic resonance imaging devices around the clock. If an MRI scanner is detected, the pacemaker automatically switches to the appropriate mode of operation. Once the patient leaves the MRI field, the implant returns to normal. This eliminates the need for healthcare professionals to manually reprogram the pacemaker before and after the scan, which speeds up the MRI procedure. In addition, medical facilities are able to significantly reduce the time spent on managing such products.
Another feature of Amvia Edge is the availability of the EarlyCheck tool, designed to simplify the workflow in the clinic by automating checks before patients are discharged. The system transmits an implant status report and an intracardiac electrocardiogram two hours after the operation, thereby eliminating the need to manually interrogate the device.
The Amvia Edge implantation procedure was performed by Dr. Raul Weiss at Mount Sinai Medical Center in Miami, Florida. According to him, the operation was successful, and the next generation pacemaker itself will provide a number of advantages for both patients and doctors.
The ability to eliminate programming devices before and after the MRI procedure is a very important achievement, and I look forward to seeing how this technology will help optimize our workflows, "said Weiss.[1] |